Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH)

Similar documents
Global review of the challenges in use of traditional medicine and WHO perspective

Global EHS Resource Center

THE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.

World Connections Committee (WCC) Report

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation

Health Task Force Workplan

A/P Regional Capacity Building Approach Overview

Essential Medicines. WHO

WORLD HEALTH ORGANIZATION

xxxx x Taej Mundkur, Ph.D. Flyway Programme Manager Wetlands International Member, Scientific Task Force of Avian Influenza

HIV / AIDS & HUMAN RIGHTS

Towards a Sustainable Global Infrastructure for Medical Countermeasures

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Promoting Public Health Dialogue between Asia and Europe

Industry and globalisation of herbal medicines

Monitoring EU Agri-Food Trade: Development until February 2018

GMI s Relationship with CCAC Discussion Paper. Background on the Climate and Clean Air Coalition to Reduce Short Lived Climate Pollutants

The Global Health Security Agenda. Ambassador Bonnie Jenkins U.S. Department of State

Update on progress of WBMT (Worldwide Network for Blood and Marrow Transplantation)

14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region

ANNEX: Trilateral Meetings since November 2015

Main developments in past 24 hours

Global situation and implementation of WHO TM strategy Dr Zhang Qi Traditional and Complementary Medicine Service Delivery and Safety

ARTEMIS. An integrated review service for radioactive waste and spent fuel management, decommissioning and remediation programmes

PROJECT DOCUMENT. Cooperative Agreement for Preventing the Spread of Communicable Diseases through Air Travel (CAPSCA)

Palliative Care in Ontario and the Declaration of Partnership and Commitment to Action

Strengthening Veterinary Services in Asia

ADDRESSING LEGAL AND POLICY BARRIERS. To Effective HIV Prevention

National Policy on Traditional / Complementary Medicine, Malaysia Ministry of Health Malaysia August 2002

1. Avian Influenza H5N1 had not occurred in Malaysia until the first case of

Internationalisation of green SMEs

Communication and Integration Strategy

Strengthening efforts to improve access to and affordability of medicines and technologies in the prevention and control of NCDs

GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA

Appendix F: Test-Curriculum Matching Analysis

Global Methane Initiative Coal Subcommittee Meeting. Monica Shimamura Director, Administrative Support Group 22 October 2014

Momentous gathering of the dental industry DenTech China 2017 The 21 st China International Exhibition & Symposium on Dental Equipment, Technology &

Singapore s Progress on GLP and MAD

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

CONNECTED HEALTH TRENDS

ASEAN+3 FETN. ASEAN Plus Three Field Epidemiology Training Network

WCO Strategic Initiatives for Trade Facilitation

The Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration

WORLD HEALTH ORGANIZATION DECISIONS

GOOD PHARMACOPOEIAL PRACTICES

t 14,081 FOLLOWERS f 28,855 FANS l 2,879 FOLLOWERS

Role of the UN agencies in the Prevention and control of NCDs Dr Jacob Kumaresan Executive Director WHO office at the United Nations

Statistics and Sustainable Development Goals. Christian Bach, September 2015

China MOH and Sanofi Pasteur Collaborations in Pandemic Preparedness. Presented by

ASEAN Activities on Increasing Access to ARV and HIV Related Supplies

Progress with GF-TADs in Asia and the Pacific Region

ASEAN and the Changing Geopolitics of Southeast Asia

PREVENTION AND CONTROL OF CARDIOVASCULAR DISEASES. Report by the Regional Director

World Health Organization Organisation mondiale de la Santé

Setting the scene Background of the Radiation Protection Culture initiative

Regulatory Capacity Building and Developing Countries: CBER Perspective

Geoffrey T. Fong, Ph.D. Department of Psychology University of Waterloo and Ontario Institute for Cancer Research

Building national capacity for implementing effective tobacco control policies

Commonwealth Secretariat

Public Health Emergencies Preparedness Planning in the Aviation Sector: The CAPSCA - Asia Pacific Story

Regional Activities Department

MARKET NEWS for pig meat

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

UNODC/HONLAF/26/CRP.1

RMIT Chinese Medicine International Collaboration in Research and Education

Louisville '19 Attachment #69

A Summary of Childhood Cancer Statistics in Australia,

Social determinants of health: outcome of the World Conference on Social Determinants of Health (Rio de Janeiro, Brazil, October 2011)

Call to Action To Accelerate Access to DR-TB Drugs: 2016 Update

International Lactation Consultant Association

ESMO ACROSS ONCOLOGY. WORLDWIDE. Josep Tabernero. ESMO President. ESMO SUMMIT MIDDLE EAST Friday, 6 th April 2018

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues

Perspective from ASEAN: WHO support activities. Health and Communicable Disease Division, ASEAN Secretariat

Cardiac Assessment Controls

Programme of Action for Cancer Therapy PACT. PROGRAMME OF ACTION FOR CANCER THERAPY

Clusters in Sports Industry: EU Approach and Support

Developing a global framework for Public Health Communication: The Tobacco Example Article 12 FCTC

Global Measles and Rubella Update. April 2018

Customs Activities in Asia and the Pacific Region regarding Hazardous Wastes

A summary of WHNCD. Proposer International Federation of Head Neck Oncologic Society (

SUMMARY ASEAN+3 FETN VIDEO CONFERENCE 10 th November 2017

International Health Regulation update and progress in the region

JOINING FORCES COLLABORATING WITH PARTNERS Annual Report

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

Press Room M0E: Vienna International Centre, Vienna, Austria MONDAY, 11 FEBRUARY 2013 (DAY 1)

Injection Techniques Questionnaire (ITQ) WorldWide Results Insulin Usage

Cardiac Assessment Controls A critical element of reliable cardiac testing

Private sector commitment to an initiative that links health and prosperity for women

There is no prevention. There is no cure.

The Regional GF-TADs Progress Report

Joint Programming in Neurodegenerative Disease Research (JPND)

State of the Network. TREAT Asia Network Annual Meeting Chiang Mai, Thailand October 2008

The National Academies

BioPlex 2200 Infectious Disease Panels

CFS MYPoW Chair Proposal on the HLPE work in 2018

PMINJ Chapter May 4 th Symposium Straight-Up Emotional Intelligence

The Test-Curriculum Matching Analysis: Science

THE ISSUE. How will this situation adversely impact on the consumer, trade and the future acceptance of TCM?

Personnel. Women in the Secretariat. Report by the Director General

Transcription:

Promotion of Regulatory Cooperation Perspectives from the International Regulatory Cooperation for Herbal Medicines (IRCH) Presentation to ICDRA Members 16 September 2008 YEE Shen Kuan Division Director (Complementary Health Products Division) Division Director (Enforcement Division) Health Products Regulation Group Health Sciences Authority Singapore

Overview Background Members of IRCH Expected Outcome of IRCH Regulatory Cooperation through IRCH Additional Functions of IRCH The Way Forward

Background (1) WHO held a working group meeting on international regulatory cooperation for herbal medicines in Ottawa, Canada, November 2005 (Hosted by Canadian government). International Regulatory Cooperation for Herbal Medicines (IRCH) was officially established in 2006. 1 st IRCH meeting was held in Beijing, China, Oct 2006 (Hosted by Chinese government). 2 nd IRCH meeting was held in Kuala Lumpur, Malaysia, July 2007 (Hosted by Malaysian government).

Background (2) Mission of IRCH To protect and promote pubic health and safety through improved regulation for herbal medicines.

Background (3) Objectives of IRCH: Promote and facilitate the safe use of herbal medicines globally, including regional initiatives, through sharing information and fostering dialogue; Facilitate and strengthen cooperation among national drug regulatory authorities by sharing experience and information related to the regulation, safety and quality of herbal medicines; Further discuss existing requirements and standards to promote the regulation, safety and quality of herbal medicines; Further share the research and knowledge of herbal medicines to reduce duplication of work; Recommend future activities related to the safe use of herbal medicines to WHO; Recommend important issues related to the safe use of herbal medicines for further discussions at ICDRA.

Background (4) The IRCH provides the platform that supports information flow and discussions among herbal medicine regulatory bodies. Canada has been the Secretariat for the IRCH for the past two years.

Members of IRCH Current membership in the IRCH network include: Australia, Brazil, Canada, China and Hong Kong SAR, Germany, Ghana, Hungary, India, Indonesia, Japan, Malaysia, Mexico, Republic of Korea, Singapore, United Arab Emirates, United Kingdom, USA. Other WHO member states are encouraged to join the network. Opportunity for future engagement of other sectors, e.g. academia, industry etc.

Expected Outcome of IRCH Development of a process that addresses/resolves issues/questions related to the regulation and safe use of herbal medicines; Establishment of a communication network and partners that fosters dialogue in regulation and safe use of herbal medicines; Development through WHO, linkages among national drug regulatory authorities and contact points for herbal medicines.

Regulatory Cooperation through IRCH (1) Opportunities for potential regulatory cooperation e.g. sharing models of regulatory decision making, best practices, work sharing etc. Opportunities for partnerships and collaboration to support more efficient regulatory decision-making process.

Regulatory Cooperation through IRCH (2) Many countries are looking towards other jurisdictions for guidance as they develop or improve their regulatory frameworks in herbal medicines. IRCH network will raise awareness and promote regulatory cooperation on herbal medicines. IRCH network will encourage countries to contribute to improved knowledge of herbal medicines and work with countries/regional bodies to ensure that the information is available to consumers.

Regulatory Cooperation through IRCH (3) WHO MedNet is the main communication vehicle for the IRCH. MedNet based IRCH discussions and announcements started in January 2007. MedNet is a tool for information exchange among member states. MedNet promotes and facilitates networking and collaboration for the WHO Traditional Medicines Programme.

Regulatory Cooperation through IRCH (4) Since January 2007, MedNet usage statistics are as follows: Announcements and requests of administrative nature - 36 Exchange of information on the safety of herbal medicines - 8 Exchange of information on the quality of herbal medicines - 2 Exchange of information on the regulatory status of herbal medicines - 14

Addition Functions of IRCH Through WHO coordination, the additional functions of IRCH are : Sharing regulatory information and responding to the requests and queries are not only limited within the member countries of IRCH. IRCH has also provided information support to nonmember countries of IRCH through WHO's coordination. Other requests and queries which are not only related to the regulatory matter of herbal medicines, can also be addressed and shared through the focal points of the member countries of IRCH. e.g., In early 2008, the South African Ministry of Health requested regulatory information on the practice of traditional medicine in targeted countries. The IRCH focal points of the Member Countries contacted the relevant offices in their countries. The collected regulatory information was, therefore, sent to South Africa through WHO.

The Way Forward Be more proactive. Strengthen relations among herbal medicine regulatory bodies worldwide. Enhance collaboration to address common scientific issues. Improve knowledge on herbal medicines and share best practices.

The 3 rd IRCH meeting will be held in Canada in February 2009

Thank You